Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Entain Share News (ENT)
ENT Share
Price
ENT Share
News
ENT Share
Chat2
ENT Share
Trades1,637
ENT
Live RNS1
ENT Share
Charts
ENT Level 2
Console
ENT Live
Share Price
ENT Broker
Ratings
ENT Directors
Deals
ENT Financial
Diary
ENT
Fundamentals
ENT Short
Positions1
ENT
Media
ENT Company
Research
ENT Company
Timeline2
Entain Information
Share Price Information for Entain (ENT)
Share Price is delayed by 15 minutes
Get Live Data
595.20
-4.80 (-0.80%)
Bid:
595.40
Ask:
596.00
Spread:
0.60 (0.101%)
Market Cap:
£3.81b
Last checked at -
Last checked at 
Intraday Entain Share Chart
Entain News
12 Aug 2021
TOP NEWS: Entain profit swells on Covid-induced online gambling boom
TOP NEWS: Entain profit swells on Covid-induced online gambling boom
12 Aug 2021
LONDON MARKET PRE-OPEN: Aviva launches GBP750 million share buyback
LONDON MARKET PRE-OPEN: Aviva launches GBP750 million share buyback
12 Aug 2021
Entain H1 profit jumps on online gambling demand
(Sharecast News) - Entain set a date for the likely restart of dividends as the sports betting company reported a sharp rise in first-half profit driv...
10 Aug 2021
LONDON MARKET CLOSE: FTSE 250 in record as stocks shrug off virus woe
LONDON MARKET CLOSE: FTSE 250 in record as stocks shrug off virus woe
22 Jul 2021
LONDON MARKET MIDDAY: FTSE 100's rebound cools ahead of ECB decision
LONDON MARKET MIDDAY: FTSE 100's rebound cools ahead of ECB decision
22 Jul 2021
BROKER RATINGS: Antofagasta, Flutter and Royal Mail get upgrades
BROKER RATINGS: Antofagasta, Flutter and Royal Mail get upgrades
19 Jul 2021
BROKER RATINGS: RBC upgrades Fresnillo; JPMorgan raises Travis Perkins
BROKER RATINGS: RBC upgrades Fresnillo; JPMorgan raises Travis Perkins
18 Jul 2021
Sunday newspaper roundup: Vectura, Sunak, Cobham
(Sharecast News) - "The head of Marlboro cigarette-maker Philip Morris International (PMI) has hit out at critics of a controversial swoop on a health...
Follow the stocks
